07.21.26 -- Exploring Dendritic Cell Therapy for Solid Tumors With Diakonos Oncology's Jay Hartenbach

Pharmaceutical labeling demands precision. Examine key considerations for ensuring accuracy and efficiency in your process, from robust control systems to diverse printing options.

Prioritizing high-quality component design and manufacturing excellence can mitigate risks, ensure long-term container closure integrity, and avoid the costly delays associated with non-compliance.

Balance compliance and efficiency in sterility testing. Explore how a risk-based approach to airflow and isolator technology aligns with Annex 1 while optimizing contamination control.

Oncology biomarkers track tumor burden and reduce radiation from imaging. Composite algorithms improve response prediction. Fit-for-purpose strategies are needed to manage logistics and costs.

Controlled aggregation and oxygen management drive consistent iPSC expansion. Parallelized systems and precise parameter control improve reproducibility for faster, confident transitions.

See how digital solutions help streamline mRNA manufacturing by reducing costs, improving efficiency, and supporting sustainability by creating paperless processes for emerging therapeutics.

Accelerate access to high-quality, cost-effective lentiviral vectors with this manufacturing platform, delivering multi-fold yield improvements and scalable, space-efficient production.

Discover how automating sterile fluid transfers removes human contamination risks, solves operator shortages, and reduces cell therapy manufacturing costs by up to 74%.

View a scalable protocol for T cell activation and expansion, designed to enhance immunotherapy workflows. This approach ensures robust T-cell growth, viability, and memory phenotypes for clinical applications. 

Gain insight into how an automated, closed workflow can integrate T cell enrichment, activation, transduction, expansion, and formulation across fresh and frozen starting materials.

In AAV manufacturing, long-term success depends not just on titers, but on maximizing the percentage of full capsids to ensure efficacy, safety, and scalability.

Informing automation decisions involves pinpointing crucial processes for successful batch productions. Prioritize automating processes with the highest risk of human error and the greatest labor cost.